Serotonin dynamics in and around the central nervous system: Is autism solvable without fundamental insights?

International Journal of Developmental Neuroscience

Volumn 39, Issue C, 2014, Pages 9-15

  Janušonis, Skirmantas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Brain; Hyperserotonemia; Platelets; Serotonin (5 hydroxytryptamine, 5 HT); Vasculature

Indexed keywords

SEROTONIN;

ANIMAL; AUTISM; BLOOD; CENTRAL NERVOUS SYSTEM; HUMAN; METABOLISM; PATHOLOGY; THROMBOCYTE;

ANIMALS; AUTISTIC DISORDER; BLOOD PLATELETS; CENTRAL NERVOUS SYSTEM; HUMANS; SEROTONIN;

EID: 84930740136     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2014.05.009     Document Type: Article

References (122)

1. Adell A., Celada P., Abellan M.T., Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res. Brain Res. Rev. 2002, 39:154-180.
2. Amaral D.G., Schumann C.M., Nordahl C.W. Neuroanatomy of autism. Trends Neurosci. 2008, 31:137-145.
3. Amisten S., Braun O.O., Bengtsson A., Erlinge D. Gene expression profiling for the identification of G-protein coupled receptors in human platelets. Thromb. Res. 2008, 122:47-57.
4. Anderson, E., Ryan, L., Xiong, H., Swindells, S., Zheng, J., Gendelman, H.E., 2004. Neural immunity and human immunodeficiency virus-1-associated dementia, in: Sharma, H.S., Westman, J. (Eds.), Blood-Spinal Cord and Brain Barriers in Health and Disease. Elsevier, San Diego, pp. 547-559.
5. Anderson, G.M., 2002. Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism. J. Am. Acad. Child Adolesc. Psychiatry 41, 1513-1516.
6. Anderson G.M. Measurement of plasma serotonin in autism. Pediatr. Neurol. 2007, 36:138-139.
7. Anderson G.M., Bennett A.J., Weld K.P., Pushkas J.G., Ocame D.M., Higley J.D. Serotonin in cisternal cerebrospinal fluid of rhesus monkeys: basal levels and effects of sertraline administration. Psychopharmacology (Berl) 2002, 161:95-99.
8. Anderson G.M., Feibel F.C., Cohen D.J. Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultrafiltrate. Life Sci. 1987, 40:1063-1070.
9. Anderson G.M., Freedman D.X., Cohen D.J., Volkmar F.R., Hoder E.L., McPhedran P., Minderaa R.B., Hansen C.R., Young J.G. Whole blood serotonin in autistic and normal subjects. J. Child Psychol. Psychiatry 1987, 28:885-900.
10. Anderson G.M., Gutknecht L., Cohen D.J., Brailly-Tabard S., Cohen J.H., Ferrari P., Roubertoux P.L., Tordjman S. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Mol. Psychiatry 2002, 7:831-836.
11. Anderson G.M., Horne W.C., Chatterjee D., Cohen D.J. The hyperserotonemia of autism. Ann. N. Y. Acad. Sci. 1990, 600:331-340.
12. Anderson G.M., Minderaa R.B., Cho S.C., Volkmar F.R., Cohen D.J. The issue of hyperserotonemia and platelet serotonin exposure: a preliminary study. J. Autism Dev. Disord. 1989, 19:349-351.
13. Anderson G.M., Ross D.L., Klykylo W., Feibel F.C., Cohen D.J. Cerebrospinal fluid indoleacetic acid in autistic subjects. J. Autism Dev. Disord. 1988, 18:259-262.
14. Anderson G.M., Stevenson J.M., Cohen D.J. Steady-state model for plasma free and platelet serotonin in man. Life Sci. 1987, 41:1777-1785.
15. Anney R., et al. A genome-wide scan for common alleles affecting risk for autism. Hum. Mol. Genet. 2010, 19:4072-4082.
16. Azmitia E.C., Singh J.S., Whitaker-Azmitia P.M. Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors. Neuropharmacology 2011, 60:1347-1354.
17. Bach, T., Syversveen, T., Kvingedal, A.M., Krobert, K.A., Brattelid, T., Kaumann, A.J., Levy, F.O., 2001. 5HT4 (a) and 5-HT4 (b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle. Naunyn Schmiedebergs Arch. Pharmacol. 363, 146-160.
18. Banerjee S., Riordan M., Bhat M.A. Genetic aspects of autism spectrum disorders: insights from animal models. Front Cell Neurosci. 2014, 8:58.
19. Beck O., Wallen N.H., Broijersen A., Larsson P.T., Hjemdahl P. On the accurate determination of serotonin in human plasma. Biochem. Biophys. Res. Commun. 1993, 196:260-266.
20. Bell J.E., Fryer A.A., Collins M., Marshall T., Jones P.W., Strange R., Hume R. Developmental profile of plasma proteins in human fetal cerebrospinal fluid and blood. Neuropathol. Appl. Neurobiol. 1991, 17:441-456.
21. Benzekhroufa, K., Liu, B., Tang, F., Teschemacher, A.G., Kasparov, S., 2009. Adenoviral vectors for highly selective gene expression in central serotomergic neurons reveal quantal characteristics of serotonin release in the rat brain. BMC Biotechnol. 9, 23.
22. Berger M., Gray J.A., Roth B.L. The expanded biology of serotonin. Annu. Rev. Med. 2009, 60:355-366.
23. Bertrand P.P., Bertrand R.L. Serotonin release and uptake in the gastrointestinal tract. Auton. Neurosci. 2010, 153:47-57.
24. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 2011, 1380:42-77.
25. Bischoff S.C., Mailer R., Pabst O., Weier G., Sedlik W., Li Z., Chen J.J., Murphy D.L., Gershon M.D. Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am. J. Physiol Gastrointest. Liver Physiol. 2009, 296:G685-G695.
26. Bonnin A., Goeden N., Chen K., Wilson M.L., King J., Shih J.C., Blakely R.D., Deneris E.S., Levitt P. A transient placental source of serotonin for the fetal forebrain. Nature 2011, 472:347-350.
27. Bonnin A., Levitt P. Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience 2011, 197:1-7.
28. Brecher G., Cronkite E.P. Morphology and enumeration of human blood platelets. J. Appl. Physiol. 1950, 3:365-377.
29. Buznikov G.A. The action of neurotransmitters and related substances on early embryogenesis. Pharmacol. Ther. 1984, 25:23-59.
30. Buznikov G.A., Lambert H.W., Lauder J.M. Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis. Cell Tissue Res. 2001, 305:177-186.
31. Buznikov G.A., Peterson R.E., Nikitina L.A., Bezuglov V.V., Lauder J.M. The pre-nervous serotonergic system of developing sea urchin embryos and larvae: pharmacologic and immunocytochemical evidence. Neurochem. Res. 2005, 30:825-837.
32. Chugani D.C., Muzik O., Behen M., Rothermel R., Janisse J.J., Lee J., Chugani H.T. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 1999, 45:287-295.
33. Cohen Z., Bonvento G., Lacombe P., Hamel E. Serotonin in the regulation of brain microcirculation. Prog. Neurobiol. 1996, 50:335-362.
34. Cohen Z., Bouchelet I., Olivier A., Villemure J.G., Ball R., Stanimirovic D.B., Hamel E. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization. J. Cereb. Blood Flow Metab. 1999, 19:908-917.
35. Cook E.H. Brief report: pathophysiology of autism: neurochemistry. J. Autism Dev. Disord. 1996, 26:221-225.
36. Courchesne E., Carper R., Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 2003, 290:337-344.
37. Courchesne E., Pierce K., Schumann C.M., Redcay E., Buckwalter J.A., Kennedy D.P., Morgan J. Mapping early brain development in autism. Neuron 2007, 56:399-413.
38. Coutinho A.M., Oliveira G., Morgadinho T., Fesel C., Macedo T.R., Bento C., Marques C., Ataide A., Miguel T., Borges L., Vicente A.M. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Mol. Psychiatry 2004, 9:264-271.
39. Coutinho A.M., Sousa I., Martins M., Correia C., Morgadinho T., Bento C., Marques C., Ataide A., Miguel T.S., Moore J.H., Oliveira G., Vicente A.M. Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum. Genet. 2007, 121:243-256.
40. Czaker R. Serotonin immunoreactivity in a highly enigmatic metazoan phylum, the pre-nervous Dicyemida. Cell Tissue Res. 2006, 326:843-850.
41. Daneman R., Zhou L., Agalliu D., Cahoy J.D., Kaushal A., Barres B.A. The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS ONE 2010, 5:e13741.
42. Derangeon M., Bozon V., Defamie N., Peineau N., Bourmeyster N., Sarrouilhe D., Argibay J.A., Herve J.C. 5-HT4 and 5-HT2 receptors antagonistically influence gap junctional coupling between rat auricular myocytes. J. Mol. Cell Cardiol. 2010, 48:220-229.
43. Duvernoy H.M., Delon S., Vannson J.L. Cortical blood vessels of the human brain. Brain Res. Bull. 1981, 7:519-579.
44. Emanuelsson H., Carlberg M., Lowkvist B. Presence of serotonin in early chick embryos. Cell Differ. 1988, 24:191-199.
45. Fatemi S.H., et al. Consensus paper: pathological role of the cerebellum in autism. Cerebellum 2012, 11:777-807.
46. Flood Z.C., Engel D.L., Simon C.C., Negherbon K.R., Murphy L.J., Tamavimok W., Anderson G.M., Janušonis S. Brain growth trajectories in mouse strains with central and peripheral serotonin differences: relevance to autism models. Neuroscience 2012, 210:286-295.
47. Fujinoki M. Serotonin-enhanced hyperactivation of hamster sperm. Reproduction 2011, 142:255-266.
48. Gadad B.S., Hewitson L., Young K.A., German D.C. Neuropathology and animal models of autism: genetic and environmental factors. Autism Res. Treat. 2013, 2013:731935.
49. Ge S., Song L., Pachter J.S. Where is the blood-brain barrier... really?. J. Neurosci. Res. 2005, 79:421-427.
50. Gershon M.D. Plasticity in serotonin control mechanisms in the gut. Curr. Opin. Pharmacol. 2003, 3:600-607.
51. Gershon M.D. Review article: serotonin receptors and transporters-roles in normal and abnormal gastrointestinal motility. Aliment. Pharmacol. Ther. 2004, 20(Suppl. 7):3-14.
52. Gershon M.D., Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007, 132:397-414.
53. Gesundheit B., Rosenzweig J.P., Naor D., Lerer B., Zachor D.A., Prochazka V., Melamed M., Kristt D.A., Steinberg A., Shulman C., Hwang P., Koren G., Walfisch A., Passweg J.R., Snowden J.A., Tamouza R., Leboyer M., Farge-Bancel D., Ashwood P. Immunological and autoimmune considerations of Autism Spectrum Disorders. J. Autoimmun. 2013, 44:1-7.
54. Hale M.W., Shekhar A., Lowry C.A. Development by environment interactions controlling tryptophan hydroxylase expression. J. Chem. Neuroanat. 2011, 41:219-226.
55. Hanley H.G., Stahl S.M., Freedman D.X. Hyperserotonemia and amine metabolites in autistic and retarded children. Arch. Gen. Psychiatry 1977, 34:521-531.
56. Hay-Schmidt A. The evolution of the serotonergic nervous system. Proc. Biol. Sci. 2000, 267:1071-1079.
57. Heyssel R.M. Determination of human platelet survival utilizing C-14-labeled serotonin. J. Clin. Invest. 1961, 40:2134-2142.
58. Hranilovic D., Bujas-Petkovic Z., Tomicic M., Bordukalo-Niksic T., Blazevic S., Cicin-Sain L. Hyperserotonemia in autism: activity of 5HT-associated platelet proteins. J. Neural Transm. 2009, 116:493-501.
59. Hranilovic D., Bujas-Petkovic Z., Vragovic R., Vuk T., Hock K., Jernej B. Hyperserotonemia in adults with autistic disorder. J. Autism Dev. Disord. 2007, 37:1934-1940.
60. Hranilovic D., Novak R., Babic M., Novokmet M., Bujas-Petkovic Z., Jernej B. Hyperserotonemia in autism: the potential role of 5HT-related gene variants. Coll. Antropol. 2008, 32(Suppl 1):75-80.
61. Hsiao E.Y. Gastrointestinal issues in autism spectrum disorder. Harv. Rev. Psychiatry 2014, 22:104-111.
62. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 1992, 72:165-229.
63. Jacobson J.D., Ellerbeck K.A., Kelly K.A., Fleming K.K., Jamison T.R., Coffey C.W., Smith C.M., Reese R.M., Sands S.A. Evidence for alterations in stimulatory G proteins and oxytocin levels in children with autism. Psychoneuroendocrinology 2014, 40:159-169.
64. Janušonis, S., 2008. Origin of the blood hyperserotonemia of autism. Theor. Biol. Med. Model. 5, 10.
65. Janušonis S. Direct interaction with no correlation: an experimental pitfall in neural systems. J. Neurosci. Methods 2012, 206:151-157.
66. Janušonis S. Relationships among variables and their equilibrium values: caveats of time-less interpretation. Biol. Rev. Camb. Philos. Soc. 2012, 87:275-289.
67. Janušonis, S., 2014. Functional associations among G protein-coupled neurotransmitter receptors in the human brain. BMC Neurosci. 15, 16.
68. Jimenez-Trejo F., Tapia-Rodriguez M., Cerbon M., Kuhn D.M., Manjarrez-Gutierrez G., Mendoza-Rodriguez C.A., Picazo O. Evidence of 5-HT components in human sperm: implications for protein tyrosine phosphorylation and the physiology of motility. Reproduction 2012, 144:677-685.
69. Kahne D., Tudorica A., Borella A., Shapiro L., Johnstone F., Huang W., Whitaker-Azmitia P.M. Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. Physiol. Behav. 2002, 75:403-410.
70. Kass-Simon G., Pierobon P. Cnidarian chemical neurotransmission, an updated overview. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2007, 146:9-25.
71. Kumar A., Vlachos I., Aertsen A., Boucsein C. Challenges of understanding brain function by selective modulation of neuronal subpopulations. Trends Neurosci. 2013, 36:579-586.
72. Lampron A., Pimentel-Coelho P.M., Rivest S. Migration of bone marrow-derived cells into the central nervous system in models of neurodegeneration. J. Comp. Neurol. 2013, 521:3863-3876.
73. Lebrand C., Cases O., Adelbrecht C., Doye A., Alvarez C., El M.S., Seif I., Gaspar P. Transient uptake and storage of serotonin in developing thalamic neurons. Neuron 1996, 17:823-835.
74. Lebrand C., Cases O., Wehrle R., Blakely R.D., Edwards R.H., Gaspar P. Transient developmental expression of monoamine transporters in the rodent forebrain. J. Comp. Neurol. 1998, 401:506-524.
75. Lebrand C., Gaspar P., Nicolas D., Hornung J.P. Transitory uptake of serotonin in the developing sensory pathways of the common marmoset. J. Comp. Neurol. 2006, 499:677-689.
76. Lee S.H., et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 2013, 45:984-994.
77. Lesch K.P., Wolozin B.L., Murphy D.L., Reiderer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J. Neurochem. 1993, 60:2319-2322.
78. Levin M., Buznikov G.A., Lauder J.M. Of minds and embryos: left-right asymmetry and the serotonergic controls of pre-neural morphogenesis. Dev. Neurosci. 2006, 28:171-185.
79. Lezoualc'h F., Steplewski K., Sartiani L., Mugelli A., Fischmeister R., Bril A. Quantitative mRNA analysis of serotonin 5-HT4 receptor isoforms, calcium handling proteins and ion channels in human atrial fibrillation. Biochem. Biophys. Res. Commun. 2007, 357:218-224.
80. Liddelow S.A., Dziegielewska K.M., Ek C.J., Habgood M.D., Bauer H., Bauer H.C., Lindsay H., Wakefield M.J., Strazielle N., Kratzer I., Mollgard K., Ghersi-Egea J.F., Saunders N.R. Mechanisms that determine the internal environment of the developing brain: a transcriptomic, functional and ultrastructural approach. PLoS ONE 2013, 8:e65629.
81. Madden, A.M., Zup, S.L., 2014. Effects of developmental hyperserotonemia on juvenile play behavior, oxytocin and serotonin receptor expression in the hypothalamus are age and sex dependent. Physiol. Behav. 128C, 260-269.
82. Manjarrez-Gutierrez G., Martinez-Radilla K., Boyzo-Montes de O.A., Orozco-Suarez S., Hernandez-Rodriguez J. Increased expression of tryptophan-5-hydroxylase 1, but not 2, in brainstem as a result of intrauterine malnutrition. Int. J. Dev. Neurosci. 2012, 30:445-450.
83. Mayorova T.D., Kosevich I.A. Serotonin-immunoreactive neural system and contractile system in the hydroid Cladonema (Cnidaria Hydrozoa). Invert. Neurosci. 2013, 13:99-106.
84. McBride P.A., Anderson G.M., Hertzig M.E., Snow M.E., Thompson S.M., Khait V.D., Shapiro T., Cohen D.J. Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. J. Am. Acad. Child Adolesc. Psychiatry 1998, 37:767-776.
85. McGarry, M.P., Protheroe, C.A., Lee, J.J., 2010. Cell differential assessments of peripheral blood films, in: McGarry, M.P., Protheroe, C.A., Lee, J.J. (eds.), Mouse Hematology: A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York, pp. 39-42.
86. McNamara, I.M., Borella, A.W., Bialowas, L.A., Whitaker-Azmitia, P.M., 2008. Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes. Brain Res. 1189, 203-214.
87. Melke J., et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol. Psychiatry 2008, 13:90-98.
88. Millan M.J., Marin P., Bockaert J., Mannoury la C.C. Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. Trends Pharmacol. Sci. 2008, 29:454-464.
89. Minderaa R.B., Anderson G.M., Volkmar F.R., Akkerhuis G.W., Cohen D.J. Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects. Biol. Psychiatry 1987, 22:933-940.
90. Moiseiwitsch J.R., Lauder J.M. Serotonin regulates mouse cranial neural crest migration. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7182-7186.
91. Mollgard K., Saunders N.R. The development of the human blood-brain and blood-CSF barriers. Neuropathol. Appl. Neurobiol. 1986, 12:337-358.
92. Mulder E.J., Anderson G.M., Kema I.P., de Bildt A., van Lang N.D., den Boer J.A., Minderaa R.B. Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates. J. Am. Acad. Child Adolesc. Psychiatry 2004, 43:491-499.
93. Nakamura K., Sugawara Y., Sawabe K., Ohashi A., Tsurui H., Xiu Y., Ohtsuji M., Lin Q.S., Nishimura H., Hasegawa H., Hirose S. Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels. J. Neurosci. 2006, 26:530-534.
94. Nakatani Y., Sato-Suzuki I., Tsujino N., Nakasato A., Seki Y., Fumoto M., Arita H. Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat. Eur. J. Neurosci. 2008, 27:2466-2472.
95. Narayan M., Srinath S., Anderson G.M., Meundi D.B. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Biol. Psychiatry 1993, 33:630-635.
96. Noriega D.B., Savelkoul H.F. Immune dysregulation in autism spectrum disorder. Eur. J. Pediatr. 2014, 173:33-43.
97. Papadopoulos G.C., Parnavelas J.G., Buijs R. Monoaminergic fibers form conventional synapses in the cerebral cortex. Neurosci. Lett. 1987, 76:275-279.
98. Parellada M., Penzol M.J., Pina L., Moreno C., Gonzalez-Vioque E., Zalsman G., Arango C. The neurobiology of autism spectrum disorders. Eur. Psychiatry 2014, 29:11-19.
99. Parnavelas J.G., Papadopoulos G.C. The monoaminergic innervation of the cerebral cortex is not diffuse and nonspecific. Trends Neurosci. 1989, 12:315-319.
100. Rodier P.M. Converging evidence for brain stem injury in autism. Dev. Psychopathol. 2002, 14:537-557.
101. Sanger G.J. 5-hydroxytryptamine and the gastrointestinal tract: where next?. Trends Pharmacol. Sci. 2008, 29:465-471.
102. Schain R.J., Freedman D.X. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J. Pediatr. 1961, 58:315-320.
103. Sharma, H.S., 2004a. Blood-brain and spinal cord barriers in stress, in: Sharma, H.S., Westman, J. (Eds.), Blood-Spinal Cord and Brain Barriers in Health and Disease. Elsevier, San Diego, pp. 231-298.
104. Sharma, H.S., 2004b. Influence of serotonin on the blood-brain and the blood-spinal cord barriers, in: Sharma, H.S., Westman, J. (Eds.), Blood-Spinal Cord and Brain Barriers in Health and Disease. Elsevier, San Diego, pp. 117-157.
105. Shuey D.L., Sadler T.W., Lauder J.M. Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors. Teratology 1992, 46:367-378.
106. Sneddon, J.M., 1973. Blood platelets as a model for monoamine-containing neurones. Prog. Neurobiol. 1, 151-198.
107. Spivak B., Golubchik P., Mozes T., Vered Y., Nechmad A., Weizman A., Strous R.D. Low platelet-poor plasma levels of serotonin in adult autistic patients. Neuropsychobiology 2004, 50:157-160.
108. Stahl S.M. The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch. Gen. Psychiatry 1977, 34:509-516.
109. Stepinska U., Kuwana T., Olszanska B. Serotonin receptors are selectively expressed in the avian germ cells and early embryos. Zygote 2014, 1-12.
110. Stuart M.J., Murphy S., Oski F.A. A simple nonradioisotope technic for the determination of platelet life-span. N. Engl. J. Med. 1975, 292:1310-1313.
111. Theoharides, T.C., Zhang, B., 2011. Neuro-inflammation, blood-brain barrier, seizures and autism. J. Neuroinflammation 8, 168.
112. Thomas D.P., Vane J.R. 5-Hydroxytryptamine in the circulation of the dog. Nature 1967, 216:335-338.
113. Tordjman S., Anderson G.M., Cohen D., Kermarrec S., Carlier M., Touitou Y., Saugier-Veber P., Lagneaux C., Chevreuil C., Verloes A. Presence of autism, hyperserotonemia, and severe expressive language impairment in Williams-Beuren syndrome. Mol. Autism 2013, 4:29.
114. Veeman M.T., Newman-Smith E., El-Nachef D., Smith W.C. The ascidian mouth opening is derived from the anterior neuropore: reassessing the mouth/neural tube relationship in chordate evolution. Dev. Biol. 2010, 344:138-149.
115. Virgintino D., Errede M., Robertson D., Capobianco C., Girolamo F., Vimercati A., Bertossi M., Roncali L. Immunolocalization of tight junction proteins in the adult and developing human brain. Histochem. Cell Biol. 2004, 122:51-59.
116. Walther D.J., Peter J.U., Bashammakh S., Hortnagl H., Voits M., Fink H., Bader M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003, 299:76.
117. Wenzel D., Felgenhauer K. The development of the blood-CSF barrier after birth. Neuropadiatrie 1976, 7:175-181.
118. Whitaker-Azmitia P.M. Serotonin and brain development: role in human developmental diseases. Brain Res. Bull. 2001, 56:479-485.
119. Whitaker-Azmitia P.M. Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?. Int. J. Dev. Neurosci. 2005, 23:75-83.
120. Wu J., Yang S., Luo H., Zeng L., Ye L., Lu Y. Quantitative evaluation of monocyte transmigration into the brain following chemical opening of the blood-brain barrier in mice. Brain Res. 2006, 1098:79-85.
121. Yang, C.J., Tan, H.P., Du, Y.J., 2014. The developmental disruptions of serotonin signaling may involved in autism during early brain development. Neuroscience 267C, 1-10.
122. Zhang X., Beaulieu J.M., Sotnikova T.D., Gainetdinov R.R., Caron M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 2004, 305:217.